Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMangoceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Mangoceuticals, Inc. Earnings Date And Information
Mangoceuticals, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 133,368 for the quarter and had revenue of 731,493 for the year. Mangoceuticals, Inc. has generated $-6 earnings per share over the last year ($-6.45 diluted earnings per share) and currently has a price-to-earnings ratio of -0.94. Mangoceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 15th, 2024 based on prior year's report dates.
Mangoceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | N/A | -$0.99 | N/A | N/A | $133,368 |
| 08/14/2024 | Q2 2024 | N/A | -$0.09 | N/A | N/A | $163,163 |
| 05/15/2024 | Q1 2024 | N/A | -$0.10 | N/A | N/A | $214,095 |
| 04/01/2024 | Q4 2023 | N/A | -$0.12 | N/A | N/A | $244,374 |
| 10/27/2023 | Q3 2023 | N/A | -$0.11 | N/A | $176,546 | $245,160 |
| 07/28/2023 | Q2 2023 | N/A | -$0.14 | N/A | $141,237 | $141,237 |
| 05/09/2023 | Q1 2023 | N/A | -$0.23 | N/A | N/A | $100,722 |
| 12/31/2022 | Q4 2022 | N/A | -$0.04 | N/A | N/A | $8,939 |
| 09/30/2022 | Q3 2022 | N/A | -$0.10 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.01 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mangoceuticals, Inc. Earnings: FAQ's
Mangoceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 15th, 2024 based offlast year's report dates.
The conference call for Mangoceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Mangoceuticals, Inc.'s latest earnings report can be read online.
Mangoceuticals, Inc. (:MGRX) has a recorded annual revenue of $731,493.
Mangoceuticals, Inc. (:MGRX) has a recorded net income of $-9,212,417.Mangoceuticals, Inc. has generated $-6.45 earnings per share over the last four quarters.
Mangoceuticals, Inc. (:MGRX) has a price-to-earnings ratio of -0.94 and price/earnings-to-growth ratio is 0.